bpc-157 safety human study adverse events Peptide BPC-157: A Prohibited Peptide and
Description
Route: The injection is typically given intramuscularly (IM) into a large muscle, such as the thigh or buttock, or subcutaneously (SC) into the subcutaneous tissue
It is not a blend, not pre-mixed, and not combined into a single vial
This is critical in safeguarding sensitive healthcare information
Delivered via slow IV infusion for best results, with doses of 250 mg, 500 mg, or 1000 mg
This is a theoretical risk, not a demonstrated one, and it should factor into who avoids this stack (see below)
& Lentze, M
